Literature DB >> 10357108

A retrospective study of ehrlichiosis in 62 dogs from North Carolina and Virginia.

J R Frank1, E B Breitschwerdt.   

Abstract

The purpose of this retrospective study is to report the clinical signs, clinicopathological findings, and response to therapy of 62 dogs from North Carolina and Virginia. Ehrlichiosis was diagnosed in all of these dogs, and previous retrospective studies of ehrlichiosis in dogs were used as a basis for comparison. In this study, the clinical signs commonly associated with ehrlichiosis were observed less frequently than in earlier studies, although previously reported laboratory abnormalities were similar. Flow cytometry revealed an inverted CD4:CD8 ratio in 3 of 4 dogs tested. This finding is suggestive of potential immune dysregulation that could predispose infected dogs to additional disease processes. Concurrent diseases were frequently reported and often contributed to death. Response to therapy was variable, with timely, complete recovery reported in only 27% of dogs; a slow, gradual, but complete recovery in 18% of dogs; an incomplete treatment response in 25% of dogs; and a presumed treatment failure in 16% of dogs.

Entities:  

Mesh:

Year:  1999        PMID: 10357108     DOI: 10.1892/0891-6640(1999)013<0194:arsoei>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  16 in total

1.  B-cell lymphoma in a dog with ehrlichiosis (Ehrlichia canis) and systemic histoplasmosis (Histoplasma capsulatum).

Authors:  Jill D Brunker; John P Hoover
Journal:  Can Vet J       Date:  2007-03       Impact factor: 1.008

2.  Molecular prevalence and haemato-biochemical profile of canine monocytic ehrlichiosis in dogs in and around Hisar, Haryana, India.

Authors:  Laxmi Bai; Parveen Goel; Ricky Jhambh; Pawan Kumar; V G Joshi
Journal:  J Parasit Dis       Date:  2016-11-09

3.  Recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool.

Authors:  A R Alleman; L J McSherry; A F Barbet; E B Breitschwerdt; H L Sorenson; M V Bowie; M Bélanger
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Clinical, serological, and molecular evidence of ehrlichiosis and anaplasmosis in dogs in Tunisia.

Authors:  Y M'ghirbi; A Ghorbel; M Amouri; A Nebaoui; S Haddad; A Bouattour
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

Review 6.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

7.  Prevalence, genetic, and biochemical evaluation of immune response of police dogs infected with Babesia vogeli.

Authors:  Ahmed Adel Zaki; Marwa Mohamed Attia; Elshaimaa Ismael; Olfat Anter Mahdy
Journal:  Vet World       Date:  2021-04-15

Review 8.  The immunopathology of canine vector-borne diseases.

Authors:  Michael J Day
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

9.  Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.

Authors:  Marjolein Lisette den Toom; Tetyda Paulina Dobak; Els Marion Broens; Chiara Valtolina
Journal:  Acta Vet Scand       Date:  2016-07-07       Impact factor: 1.695

Review 10.  Ehrlichioses: An Important One Health Opportunity.

Authors:  Tais B Saito; David H Walker
Journal:  Vet Sci       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.